Hyperlipidemia Patient Recruitment in Indiana

TheraNovex connects clinical trial sponsors with pre-screened, eligible Hyperlipidemia patients across Indiana, including Indianapolis, Fort Wayne, Evansville, and beyond.

Hyperlipidemia patient recruitment for LDL-lowering, PCSK9 inhibitor, and cardiovascular risk reduction trials.

Who qualifies: Adults with elevated LDL-C (≥70–190 mg/dL) with or without statin intolerance.

Recruitment challenges: Fasting lipid panel requirements and prior statin therapy eligibility criteria.

Our approach: Primary care, cardiology, and endocrinology referral networks with lipid panel pre-screening.

Our recruitment network spans all major metropolitan areas in Indiana, ensuring broad geographic coverage for your Hyperlipidemia trial.